Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSIG Regulatory News (SHI)

Share Price Information for SIG (SHI)

Share Price is delayed by 15 minutes
Get Live Data
8.16    0.21 (2.64%)
Bid:
8.00
Ask:
8.99
Spread: 0.99 (12.375%)
Market Cap: £94.31m
SHI Live PriceLast checked at - London Stock Exchange

Intraday SIG Share Chart

Director/PDMR Shareholding

1 Dec 2023 17:42

RNS Number : 4698V
SIG PLC
01 December 2023

LEI: 213800VDC1BKJEZ8PV53 1 December 2023

SIG plc

("SIG" or the "Company")

Notification and public disclosure of Exercise of Restricted Share Plan Awards by Directors/Persons Discharging Managerial Responsibilities and their Closely Associated Persons

Exercise of 2020 Restricted Share Plan ("RSP") Awards

SIG plc announces that on 1 December 2023 Ian Ashton, Chief Financial Officer, exercised nil cost options (the Options) under the RSP to acquire 1,250,000 shares of 10 pence each in the capital of the Company (Shares). 587,564 Shares were sold on 1 December 2023 to realise funds to settle income tax and national insurance obligations arising on exercise of the Options. The balance of 662,436 Shares were retained by him and are subject to a holding period of two years under the RSP rules and the Directors' Remuneration Policy.

This announcement and the following disclosures are made in accordance with the UK Market Abuse Regulation.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Ian Ashton

2

Reason for the notification

a)

Position/status

PDMR (Chief Financial Officer)

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

SIG plc

b)

LEI

213800VDC1BKJEZ8PV53

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10p each in SIG plc

ISIN: GB0008025412

b)

Nature of the transaction

Vesting of share awards granted on 1 December 2020 under the SIG plc 2020 Restricted Share Plan

c)

Price(s) and volume(s)

Price(s)

Volume(s)

GBP Nil

1,250,000

d)

Aggregated information

- Aggregated volume

- Price

Not applicable - single transaction

e)

Date of the transaction

1 December 2023

f)

Place of the transaction

Outside a trading venue

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10p

ISIN: GB0008025412

b)

Nature of the transaction

Sale of shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

GBP 0.28725

587,564

d)

Aggregated information

- Aggregated volume

- Price

Aggregate Price

Aggregate Volume

Aggregate Total

GBP 0.28725

587,564

GBP 168,777.76

e)

Date of the transaction

1 December 2023

f)

Place of the transaction

London Stock Exchange, Main Market XLON

Enquiries

SIG plc

Andrew Watkins, Group General Counsel & Company Secretary +44 (0) 0114 285 6300

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHFSSFWFEDSELE
Date   Source Headline
8th Jun 20264:44 pmRNSDirector/PDMR Shareholding
3rd Jun 20263:50 pmRNSDirector/PDMR Shareholding
28th May 20262:56 pmRNSDirector/PDMR Shareholding
22nd May 20261:36 pmRNSDirector/PDMR Shareholding
22nd May 20261:29 pmRNSDirector/PDMR Shareholding
22nd May 20261:18 pmRNSResult of Meeting
20th May 20263:07 pmRNSDirector/PDMR Shareholding
14th May 20264:44 pmRNSDirector/PDMR Shareholding
13th May 20265:27 pmRNSDirector/PDMR Shareholding
6th May 202611:11 amRNSDirector/PDMR Shareholding
6th May 202610:24 amRNSNotice of GM
30th Apr 20262:00 pmRNSResult of AGM
30th Apr 20267:01 amRNSTrading Update
30th Apr 20267:00 amRNSAppointment of Chief Financial Officer
10th Apr 20267:00 amRNSDirectorate change
23rd Mar 202610:57 amRNSDirector/PDMR Shareholding
23rd Mar 20269:59 amRNSNotice of AGM
4th Mar 202610:18 amRNSAnnual Financial Report
4th Mar 20267:00 amRNSFull year results for year ended 31 December 2025
15th Jan 20264:02 pmRNSDirector/PDMR Shareholding
13th Jan 20267:00 amRNS2025 Full Year Trading Update & Strategy Framework
19th Dec 20257:00 amRNSNotice of Trading & Business Update
19th Dec 20257:00 amRNSNotice of Trading & Business Update
23rd Oct 202511:05 amRNSDirector/PDMR Shareholding
17th Oct 20257:00 amRNSQ3 Trading Update
1st Oct 20259:00 amRNSDirector/PDMR Shareholding
3rd Sep 202510:54 amRNSHolding(s) in Company
28th Aug 20251:02 pmRNSResult of Meeting
8th Aug 202511:01 amRNSNotice of GM
5th Aug 20257:00 amRNSResults for the six months to 30 June 2025
8th Jul 20257:01 amRNSAppointment of CEO and Chair designate
8th Jul 20257:00 amRNSH1 Trading Update
9th May 20257:00 amRNSDirectorate Change
6th May 20253:00 pmRNSHolding(s) in Company
1st May 20253:12 pmRNSResult of AGM
30th Apr 20257:00 amRNSTrading Update
10th Apr 20254:02 pmRNSDirector/PDMR Shareholding
4th Apr 202511:10 amRNSDirector/PDMR Shareholding
1st Apr 20254:00 pmRNSHolding(s) in Company
28th Mar 20255:03 pmRNSDirector/PDMR Shareholding
28th Mar 20254:59 pmRNSDirector/PDMR Shareholding
24th Mar 202510:06 amRNSNotice of AGM
21st Mar 20254:44 pmRNSDirector/PDMR Shareholding
12th Mar 20259:06 amRNSDirector/PDMR Shareholding
12th Mar 20258:54 amRNSDirectorate Change
10th Mar 20258:32 amRNSDirector/PDMR Shareholding
5th Mar 202511:17 amRNSAnnual Financial Report
5th Mar 20257:00 amRNSFull year results for year ended 31 December 2024
4th Mar 202512:52 pmRNSHolding(s) in Company
19th Feb 20257:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.